Effects of enoxaparin injection: A Synthesis of Findings from 18 Studies
- Home
- Effects of enoxaparin injection
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of enoxaparin injection: A Synthesis of Findings from 18 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
Enoxaparin is a low molecular weight heparin (LMWH) that is commonly used to prevent blood clots in high-risk patients. 11 , 8 . However, it can cause a rare side effect called reactive thrombocytosis, where platelet count increases after enoxaparin administration. 8 . Another potential complication is hematoma of the rectus sheath, which can occur following subcutaneous enoxaparin injection. 11 . The study also found that the speed at which the injection is administered and the duration the needle remains in the tissue after injection can affect the size and occurrence of bruising. 10 . Injecting enoxaparin over a longer duration (30 seconds) and keeping the needle in the tissue for an additional 10 seconds after injection can help reduce the size of bruising. 10 . Additionally, a study comparing the efficacy and safety of enoxaparin with intermittent pneumatic compression (IPC) for preventing venous thromboembolism (VTE) in Japanese surgical patients with gynecologic malignancy found that both methods were effective. 3 . Rivaroxaban, a direct oral anticoagulant, is showing promise as a less burdensome alternative to enoxaparin for pediatric patients with congenital heart disease. 13 .
Benefits and Risks
Benefit Summary
Enoxaparin is effective in preventing blood clots, particularly after heart surgery and colorectal cancer surgery. 9 , 3 . It also shows promise as a less burdensome alternative to enoxaparin for pediatric patients with congenital heart disease. 13 .
Risk Summary
Enoxaparin can cause side effects such as bruising, reactive thrombocytosis, and allergic reactions. 11 , 8 . The risk of bruising can be influenced by the injection speed and the duration the needle remains in the tissue. 10 .
Comparison of Studies
Similarities of Studies
Many studies evaluate the safety and efficacy of enoxaparin. 11 , 8 , 9 , 3 , 13 , 10 , , 16 , 7 , , 4 , 2 , 12 , 17 , 15 , 14 , 1 .
Differences of Studies
The diseases, surgeries, methods of administering enoxaparin, and evaluation criteria vary between studies. 11 , 8 , 9 , 3 , 13 , 10 , , 16 , 7 , , 4 , 2 , 12 , 17 , 15 , 14 , 1 .
Consistency and Contradictions of Results
Enoxaparin has been shown to be effective in preventing blood clots. 9 , 3 . However, it can cause side effects such as bruising, reactive thrombocytosis, and allergic reactions. 11 , 8 , . Further research is needed on enoxaparin's administration methods and side effects. 8 .
Implications for Daily Life
When administering enoxaparin, it's crucial to be aware of the potential risks of hematoma and bruising. 11 , 10 . Injecting enoxaparin over a longer duration and keeping the needle in the tissue for a few seconds after injection can help reduce the size and occurrence of bruising. 10 . If you experience bleeding after enoxaparin administration, consult with your doctor. 4 .
Limitations of Current Research
Research on enoxaparin's side effects is still limited. 8 . Further research is needed on enoxaparin's administration methods and side effects. 8 .
Directions for Future Research
Large-scale clinical trials are needed to evaluate the safety and efficacy of enoxaparin more thoroughly. 8 . Further research on enoxaparin's administration methods, the mechanisms behind its side effects, and ways to reduce side effects is also crucial. 8 , 10 .
Conclusion
Enoxaparin is a commonly used low molecular weight heparin for preventing deep vein thrombosis. 11 , 8 . It can cause side effects such as bruising, reactive thrombocytosis, and allergic reactions. 11 , 8 , . Further research is needed on enoxaparin's administration methods and side effects. 8 . Before administering enoxaparin, it's essential to consult with your doctor and understand the risks and benefits of the medication. Use it with caution.
Benefit Keywords
Risk Keywords
Article Type
Author: ErtaşNilgün Markal, GoldmanCorey, DeitcherSteven, SiemionowMaria
Language : English
Author: DuncanS M, MassicotteM P, RayL, KuhleS, BaumanM E
Language : English
Author: NagataChie, TanabeHiroshi, TakakuraSatoshi, NaruiChikage, SaitoMotoaki, YanaiharaNozomu, OkamotoAikou
Language : English
[The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
Author: LaiSilvia, BarbanoBiagio, CianciRosario, GiganteAntonietta, Di DonatoDomenico, AsllanajBledian, DimkoMira, MariottiAmalia, MorabitoSanto, PuglieseFrancesco
Language : Italian
Author: BagheriZahra, AziziAzim, OshvandiKhodayar, MohammadiYounes, Larki-HarcheganiAmir
Language : English
Author: ImamuraHajime, AdachiTomohiko, KitasatoAmane, TanakaTakayuki, SoyamaAkihiko, HidakaMasaaki, FujitaFumihiko, TakatsukiMitsuhisa, KurokiTamotsu, EguchiSusumu
Language : English
Author: AlmannieRaed M, AlkhamisWaleed H
Language : English
Author: MeenpidiyilSaleel Salman, AzeezShihas, KumarVaisakh Prasanna, SureshDhanush, KalathathoduuillSareena, ThanduparaSafa, PuthukudiMuhammed Hashik
Language : English
Author: LobastovKirill, DementievaGalina, SoshitovaNatalia, BargandzhiyaAstanda, BarinovVictor, LaberkoLeonid, RodomanGrigoriy
Language : English
Author: UzunSenay, AciksozSemra, ArslanFiliz, YildizCemil, AkyolMesut
Language : English
Author: FiroozbakhshShahram, ParsaeiReza, JafarshadReyhaneh
Language : English
Author: VillanuevaC A, NájeraL, EspinosaP, BorbujoJ
Language : English
Author: DuranSilvestre, GerberChristina, BilskyShannon, PlummerSarah, BocksMartin
Language : English
Author: CabañasR, CaballeroM T, López-SerranoM C, DíazR, ContrerasJ, BarrancoP, Moreno-AncilloA
Language : English
Author: MéndezJ, SanchísM E, de la FuenteR, StolleR, VegaJ M, MartínezC, ArmentiaA, SánchezP, FernándezA
Language : English
Author: BittencourtMaria Cecilia Borges, AtanazioMarcelo Junqueira, XavierErick Menezes, CostaSilvia Figueiredo
Language : English
Author: MoattiD, MeirhaegheA, OllivierV, BautersC, AmouyelP, de ProstD
Language : English
Author: MéndezJ, SanchísM E, de la FuenteR, StolleR, VegaJ M, MartínezC, ArmentiaA, SánchezP, FernándezA
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.